Posted on 06/26/2002 1:21:12 AM PDT by kattracks
Edited on 05/26/2004 5:07:00 PM PDT by Jim Robinson. [history]
June 26, 2002 -- Executives close to ImClone had firmer and earlier evidence than first believed that their application for the much-hyped cancer drug Erbitux faced government rejection, a newly disclosed e-mail shows.
A Dec. 24 e-mail by Alan Bennett, a lawyer for Bristol Myers Squibb - ImClone's Erbitux partner - cited a Food and Drug Administration warning that a rejection of the drug's application called a "refusal to file letter," or RTF, was coming.
(Excerpt) Read more at nypost.com ...
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.